Article ; Online: Total metabolic tumor volume on
Journal for immunotherapy of cancer
2024 Volume 12, Issue 4
Abstract: Purpose: Because of atypical response imaging patterns in patients with metastatic non-small cell lung cancer (NSCLC) treated with immune checkpoint inhibitors (ICPIs), new biomarkers are needed for a better monitoring of treatment efficacy. The aim of ... ...
Abstract | Purpose: Because of atypical response imaging patterns in patients with metastatic non-small cell lung cancer (NSCLC) treated with immune checkpoint inhibitors (ICPIs), new biomarkers are needed for a better monitoring of treatment efficacy. The aim of this prospective study was to evaluate the prognostic value of volume-derived positron-emission tomography (PET) parameters on baseline and follow-up Methods: Patients with metastatic NSCLC were included in two different single-center prospective trials. Results: 110 patients were prospectively included. On PET Conclusion: The absolute value of residual metabolic tumor volume, assessed 6-8 weeks after the start of ICPI, is an optimal and independent prognostic measure, exceeding and complementing conventional PERCIST criteria. Oncologists should consider it in patients with first tumor progression according to PERCIST criteria, as it helps identify patients who benefit from continued treatment. Trial registration number: 2018-A02116-49; NCT03584334. |
---|---|
MeSH term(s) | Humans ; Fluorodeoxyglucose F18 ; Male ; Lung Neoplasms/diagnostic imaging ; Lung Neoplasms/pathology ; Positron Emission Tomography Computed Tomography/methods ; Female ; Middle Aged ; Aged ; Tumor Burden ; Immunotherapy/methods ; Prospective Studies ; Carcinoma, Non-Small-Cell Lung/diagnostic imaging ; Carcinoma, Non-Small-Cell Lung/pathology ; Carcinoma, Non-Small-Cell Lung/drug therapy ; Carcinoma, Non-Small-Cell Lung/metabolism ; Adult ; Neoplasm Metastasis ; Immune Checkpoint Inhibitors/therapeutic use ; Immune Checkpoint Inhibitors/pharmacology ; Aged, 80 and over |
Chemical Substances | Fluorodeoxyglucose F18 (0Z5B2CJX4D) ; Immune Checkpoint Inhibitors |
Language | English |
Publishing date | 2024-04-22 |
Publishing country | England |
Document type | Journal Article ; Research Support, Non-U.S. Gov't |
ZDB-ID | 2719863-7 |
ISSN | 2051-1426 ; 2051-1426 |
ISSN (online) | 2051-1426 |
ISSN | 2051-1426 |
DOI | 10.1136/jitc-2023-007628 |
Database | MEDical Literature Analysis and Retrieval System OnLINE |
More links
Kategorien
Order via subito
This service is chargeable due to the Delivery terms set by subito. Orders including an article and supplementary material will be classified as separate orders. In these cases, fees will be demanded for each order.